MedTrace Logo

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

NCT03232437 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2017-07-28

No results posted yet for this study

Summary

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites:

1. Forsyth Institute in Cambridge, MA
2. Orange County Research Center in Tustin, CA
3. ActivMed Practices \& Research in Methuen, MA

Conditions

Interventions

DEVICE

Aina HbA1c Monitoring System

Monitoring test for quantitative determination of HbA1c

Sponsors & Collaborators

  • The Forsyth Institute

    collaborator OTHER

  • Orange County Research Center

    collaborator OTHER

  • ActivMed Practices & Research

    collaborator OTHER

  • Jana Care

    lead INDUSTRY

Principal Investigators

  • Hatice Hasturk, PhD · Forsyth Institute

  • Joel Neutel, MD · Orange County Research Center

  • Michael McCartney, MD · ActivMed Practices & Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2017-06-21
Completion
2017-06-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232437 on ClinicalTrials.gov